Heritage Pharmaceuticals Recalls Clindamycin Palmitate Hydrochloride Due to Foreign Particles
Heritage Pharmaceuticals is recalling Clindamycin Palmitate Hydrochloride oral solution due to the presence of particles and white flakes in reconstituted bottles.
What this means for you
Minor labeling or packaging issue, or a voluntary precautionary recall. Risk of harm is low but real — follow the manufacturer's instructions.
Our severity reasoning: The recall is classified as FDA Class II, and the hazard involves foreign particles without reported injuries or illnesses, fitting the criteria for a moderate severity recall.
Plain-English summary
Heritage Pharmaceuticals Inc. is recalling Clindamycin Palmitate Hydrochloride for Oral Solution, USP, 75 mg/5 mL, 100 mL bottles. The recall is due to the presence of foreign substances, specifically particles and white flakes, found in the reconstituted bottles.
The affected product is identified by Lot # 2411550 with an expiration date of November 2026. The product is distributed nationwide within the U.S. by Avet Pharmaceuticals Inc. in East Brunswick, NJ.
Consumers and healthcare providers should stop using the affected product and contact their healthcare provider or the recalling firm for further instructions.
The recalled product
- Product
- CLINDAMYCIN PALMITATE HYDROCHLORIDE (CLINDAMYCIN PALMITATE HYDROCHLORIDE)
- Brand
- CLINDAMYCIN PALMITATE HYDROCHLORIDE
- Manufacturer
- Heritage Pharmaceuticals Inc
- Category
- Drug — Antibiotic
- Hazard
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 2411550
- Exp. 2026/NOV.
Distribution
Distributed nationwide across the United States.
Related recalls
Same manufacturer · Heritage Pharmaceuticals Inc
See all →- HighDesipramine 100 mg tablets recalled over nitrosamine impurity above intake limit
FDA (Drugs) · 2025-11-05
- HighDesipramine 25 mg tablets recalled over nitrosamine impurity above intake limit
FDA (Drugs) · 2025-11-05
- HighDesipramine 75 mg tablets recalled over nitrosamine impurity above intake limit
FDA (Drugs) · 2025-11-05
- HighDesipramine 50 mg tablets recalled over nitrosamine impurity above intake limit
FDA (Drugs) · 2025-11-05
- HighDesipramine tablets recalled over nitrosamine impurity above acceptable daily intake
FDA (Drugs) · 2025-11-05
Same hazard · foreign substance
See all →- HighPrednisolone Acetate Ophthalmic Suspension Recalled for Foreign Substance
FDA (Drugs) · 2026-07-08
- LowHydroxyzine Hydrochloride Oral Solution recalled for foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor ivabradine tablets recalled for presence of foreign substance
FDA (Drugs) · 2026-07-01
- ModerateCorlanor Ivabradine Tablets Recalled for Foreign Substance Contamination
FDA (Drugs) · 2026-07-01
- HighBudesonide inhalation ampules contain black and brown specks and particles
FDA (Drugs) · 2026-06-17